91AV

Introduction

Over 150 delegates representing global pharmaceutical organisations, leading biotech companies and internationally renowned academic institutions.

Over 40 presentations and case studies focused on the key issues in Biomanufacturing & Biologics Product Development.

Including 4 interactive streams:

• Biologics Manufacturing, CMC & Continuous Biomanufacturing
• Cell & Gene Therapy Manufacturing: Insights, Key Strategies & Novel Approaches
• Upstream Processing, Digitalisation, Smart Factories, Tools & Technologies
• Downstream Bioprocessing: Recent Technological Advancements and Latest Trends

Useful links

Speakers

• Claus Tollnick Managing Director, Ferring Pharmaceuticals, United Kingdom
• Jan Jezek Chief Scientific Officer, Arecor, United Kingdom
• David Sourdive Executive Vice President, Technical Operations, Cellectis, United Kingdom
• Daniela Ottini Vice President, Biologics Manufacturing, AbbVie, United Kingdom

---

Venue

Novotel London West

Novotel London West, 1 Shortlands, Hammersmith International Ctre, Hammersmith, London, W6 8DR , United Kingdom

Committee

• Guillaume Alonso Marketing and CRM Manager, United States

---

Organised by

Contact information

Guillaume Alonso
Oxford Global
Part 1st Floor
Godstow Court
Minns Business Park
Botley
Oxford
OX2 0JB
+441865248455
Contact us by email

---